http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H0827026-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6c8d4dc7bd1a30d8fda907fceaeb4e69 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-46 |
| filingDate | 1994-07-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2af1501ee0d01ddc444e0b43bcddfe03 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_55b69f0044da0e86704459f0400542d0 |
| publicationDate | 1996-01-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-H0827026-A |
| titleOfInvention | Preventive and therapeutic drug for liver disease |
| abstract | (57) [Summary] [Structure] A liver disease containing an active ingredient of a protease that acts on an inactive single-chain human hepatocyte growth factor to induce an active double-chain human hepatocyte growth factor Preventive and therapeutic drugs. [Effect] Since the protease which is an active ingredient in the present invention can increase the amount of active HGF in liver diseases such as acute hepatitis, fulminant hepatitis, chronic hepatitis and liver cirrhosis, It is effective as an indirect drug against these liver diseases. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H0840930-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9824467-A1 |
| priorityDate | 1994-07-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 487.